-Background: Hemodialysis (HD)-related headaches are a common complaint of patients undergoing this procedure. Objective: To determine the frequency and clinical characteristics of headache in patients undergoing HD and to discuss their diagnostic criteria. Method: The present study assessed, in a prospective manner, a series of patients consulting at a HD center in Aracaju, Sergipe, Brazil, from November 2007 to January 2008. Only patients with HD-related headaches without previous history of primary headache were diagnosed as isolated HD headache (HDH). Results: Headache was reported by 76.1% of the patients studied. Prior to beginning dialysis, 47.9% had migraine without aura, 6.7% migraine with aura, 0.6% hemiplegic migraine, 5% episodic tension-type headache, and 2.5% migraine and tension-type headache. HDH was diagnosed in 6.7% of the patients, the most prevalent features being diffuse or temporal region location, bilateral headache, throbbing nature, and moderate severity. Seven patients with headaches between the sessions were not classified. Conclusion: While the pathophysiology of HDH is unknown, to diagnose patients with HDH or other possible HD-related headaches remains a challenge.Key WOrDS: hemodialysis headache, end-stage renal, clinical description, diagnostic criteria. Caracterização clínica da cefaléia da diálise em pacientes renais crônicosResumo -Cefaléias relacionadas ao programa de hemodiálise é uma queixa comum. Objetivo: Determinar freqüência e características clínicas das cefaléias em pacientes em regime de hemodiálise e discutir critérios diagnósticos. Método: Foi feita uma avaliação clínica prospectiva de pacientes cefalêicos em um serviço de hemodiálise em Aracaju, Sergipe, Brasil, de novembro de 2007 a janeiro de 2008. Apenas pacientes sem antecedente de cefaléia primária receberam diagnóstico de cefaléia da diálise isolada. Resultados: Cefaléia esteve presente em 76,1% dos pacientes estudados. Como antecedente de cefaléia, 47,9% tinham migrânea sem aura, 6,7% migrânea com aura, 0,6% migrânea hemiplégica, 5,5% cefaléia tensional episódica, e 2,5% associação de migrânea e cefaléia tensional. A cefaléia da diálise isolada foi diagnosticada em 6,7% dos pacientes e as localizações difusas e temporais, cefaléia bilateral, pulsátil, e intensidade moderada foram as características mais prevalentes. Conclusão: enquanto a fisiopatologia da cefaléia da diálise for desconhecida, o diagnostico da cefaléia da diálise ou de outras possíveis cefaléias relacionadas à diálise permanecerá um desafio.PAlAvrAS-CHAve: cefaléia da diálise, insuficiência renal terminal, características clínicas, critérios diagnósticos.
Chronic migraine is recognized as a migraine complication and is characterized by frequency of attacks up to 15 days/ month for more than three months, in absence of painkiller abusive usage. Studies indicate that magnesium ion plays a role in migraine pathophysiology but, until now, they have never included only patients with chronic migraine as their population. Objective: To compare serum magnesium levels etween treated and non-treated chronic migraineurs. Methods: Twenty-two patients with chronic migraine were selected and divided in two groups (treated and non-treated), matched by sex and age, and submitted to serum dosage of magnesium ion for latter comparison. Result: The non-treated chronic migraineurs presented serum magnesium ion level within normal limits, but lower than those found in the treated group with a statistically significant difference. Conclusion: Similarly to other studies in the literature, this study stresses the importance of magnesium ion in the migraine pathophysiology, but studying only the chronic migraine patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
334 Leonard St
Brooklyn, NY 11211
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.